| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 3FO6689MSD |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | Complement C5 binding agent | PubMed ClinicalTrials |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Macular Degeneration | 2 | D008268 | ClinicalTrials |
| Wet Macular Degeneration | 2 | D057135 | ClinicalTrials |
| Uveitis, Intermediate | 2 | D015867 | ClinicalTrials |
| Hemoglobinuria, Paroxysmal | 2 | D006457 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4298012 |
| FDA SRS | 3FO6689MSD |
CONTENTS